APA-referens

Ramírez Sevilla, C., Gómez Lanza, E., Manzanera, J. L., Martín, J. A. R., & Sanz, M. Á. B. (2019). Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects. BMC Infect Dis.

Chicago-stil citat

Ramírez Sevilla, Cristóbal, Esther Gómez Lanza, Juan Llopis Manzanera, Jose Antonio Romero Martín, och Miguel Ángel Barranco Sanz. "Active Immunoprophyilaxis With Uromune® Decreases the Recurrence of Urinary Tract Infections At Three and Six Months After Treatment Without Relevant Secondary Effects." BMC Infect Dis 2019.

MLA-referens

Ramírez Sevilla, Cristóbal, et al. "Active Immunoprophyilaxis With Uromune® Decreases the Recurrence of Urinary Tract Infections At Three and Six Months After Treatment Without Relevant Secondary Effects." BMC Infect Dis 2019.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.